Mostrar o rexistro simple do ítem

dc.contributor.authorCrujeiras, A. B.
dc.contributor.authorIzquierdo, Andrea G.
dc.contributor.authorPrimo, David
dc.contributor.authorMilagro, F
dc.contributor.authorSajoux, Ignacio
dc.contributor.authorJácome, M. A.
dc.contributor.authorFernández-Quintela, Alfredo
dc.contributor.authorPortillo, Maria P.
dc.contributor.authorMartínez, J.A.
dc.contributor.authorMartínez Olmos, Miguel Ángel
dc.contributor.authorLuis, Daniel de
dc.contributor.authorCasanueva, F.
dc.date.accessioned2021-09-06T16:15:00Z
dc.date.available2021-09-06T16:15:00Z
dc.date.issued2021
dc.identifier.citationCRUJEIRAS, A.B., IZQUIERDO, A.G., PRIMO, D., MILAGRO, F.I., SAJOUX, I., JÁCOME, A., FERNANDEZ-QUINTELA, A., PORTILLO, M.P., MARTÍNEZ, J.A., MARTINEZ-OLMOS, M.A., DE LUIS, D. y CASANUEVA, F.F., 2021. Epigenetic landscape in blood leukocytes following ketosis and weight loss induced by a very low calorie ketogenic diet (VLCKD) in patients with obesity. Clinical Nutrition, vol. 40, no. 6, pp. 3959-3972. ISSN 0261-5614. DOI 10.1016/j.clnu.2021.05.010.es_ES
dc.identifier.urihttp://hdl.handle.net/2183/28429
dc.description.abstract[Abstract] Background:The molecular mechanisms underlying the potential health benefits of a ketogenic diet areunknown and could be mediated by epigenetic mechanisms.Objective:To identify the changes in the obesity-related methylome that are mediated by the inducedweight loss or are dependent on ketosis in subjects with obesity underwent a very-low calorie ketogenicdiet (VLCKD).Methods:Twenty-one patients with obesity (n¼12 women, 47.9±1.02 yr, 33.0±0.2 kg/m2) after 6months on a VLCKD and 12 normal weight volunteers (n¼6 women, 50.3±6.2 yrs, 22.7±1.5 kg/m2)were studied. Data from the Infinium MethylationEPIC BeadChip methylomes of blood leukocytes wereobtained at time points of ketotic phases (basal, maximum ketosis, and out of ketosis) during VLCKD(n¼10) and at baseline in volunteers (n¼12). Results were further validated by pyrosequencing inrepresentative cohort of patients on a VLCKD (n¼18) and correlated with gene expression.Results:After weight reduction by VLCKD, differences were found at 988 CpG sites (786 unique genes).The VLCKD altered methylation levels in patients with obesity had high resemblance with those fromnormal weight volunteers and was concomitant with a downregulation of DNA methyltransferases(DNMT)1, 3a and 3b. Most of the encoded genes were involved in metabolic processes, protein meta-bolism, and muscle, organ, and skeletal system development. Novel genes representing the top scoringassociated events were identified, includingZNF331,FGFRL1(VLCKD-induced weight loss) andCBFA2T3,C3orf38,JSRP1, andLRFN4(VLCKD-induced ketosis). Interestingly,ZNF331andFGFRL1were validated inan independent cohort and inversely correlated with gene expression.Conclusions:The beneficial effects of VLCKD therapy on obesity involve a methylome more suggestive ofnormal weight that could be mainly mediated by the VLCKD-induced ketosis rather than weight loss.es_ES
dc.description.sponsorshipThis work was supported by the PronoKal Group® and grants from the Fondo de Investigacion Sanitaria as well as PI17/01287, PI20/00628 and PI20/00650 research projects and CIBERobn from the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigación; Fondo Europeo de Desarrollo Regional (FEDER) Ana B Crujeiras is funded by a research contract “Miguel Servet” (CP17/00088) from the ISCIII, co-financed by the European Regional Development Fund (FEDER) and Xunta de Galicia-GAIN (IN607B2020)es_ES
dc.description.sponsorshipXunta de Galicia; IN607B2020es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/PI17%2F01287/ES/IDENTIFICACION DE BIOMARCADORES EPIGENEOMICOS DE OBESIDAD INDICATIVOS DE SUSCEPTIBILIDAD A DIFERENTES TRATAMIENTOS Y RE-GANANCIA DE PESO CORPORAL/
dc.relationinfo:eu-repo/grantAgreement/MICINN/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PI20%2F00628/ES/Identificación de biomarcadores objetivos de obesidad, tratamiento personalizado y predicción de re-ganancia de peso corporal
dc.relationinfo:eu-repo/grantAgreement/MICINN/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PI20%2F00650/ES/Evaluación del efecto de la pérdida de peso inducida por intervención nutricional durante el tratamiento oncológico sobre las marcas epigenéticas y el pronóstico del cáncer de mama asociado a la obesidad
dc.relationinfo:eu-repo/grantAgreement/MICINN/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/CP17%2F00088/ES/
dc.relation.urihttps://doi.org/10.1016/j.clnu.2021.05.010es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacionales_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAdiposityes_ES
dc.subjectMethylationes_ES
dc.subjectNutritional interventiones_ES
dc.subjectCirculating blood cellses_ES
dc.subjectBiomarkerses_ES
dc.titleEpigenetic Landscape in Blood Leukocytes Following Ketosis and Weight Loss Induced by a Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Obesityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleClinical Nutritiones_ES
UDC.volume40es_ES
UDC.issue6es_ES
UDC.startPage3959es_ES
UDC.endPage3972es_ES
dc.identifier.doi10.1016/j.clnu.2021.05.010


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem